# Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery

> **NCT05898074** · NA · RECRUITING · sponsor: **Indiana University** · enrollment: 30 (estimated)

## Conditions studied

- Skull Base Neoplasms
- Cerebrospinal Fluid Leakage
- Nasal; Hypertrophy, Mucous Membrane (Septum)

## Interventions

- **DEVICE:** Non-Absorbable Packing (Silastic Splint)
- **DEVICE:** PuraGel (RADA16) Hydrogel

## Key facts

- **NCT ID:** NCT05898074
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-09
- **Primary completion:** 2026-06-09
- **Final completion:** 2026-06-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05898074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05898074, "Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05898074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*